ReviewJournal of assisted reproduction and genetics2025
Transcriptomics empower assisted reproductive technology in decoding gamete and embryo development potential: a review.
Review in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Transcriptomics has emerged as a crucial methodology for deciphering gene expression and regulatory networks, offering novel insights and robust scientific support for advancing assisted reproductive technologies (ART). This review synthesizes current knowledge on the transcriptome profiles of germ cells and early embryos, elucidating key molecular signatures associated with developmental potential, maturation processes, and embryo quality. It further demonstrates the application of transcriptomics in preimplantation genetic testing (PGT), enhancing embryo selection precision through the screening of chromosomal abnormalities and genetic disorders. Additionally, the review highlights the significant value of transcriptomic approaches in evaluating embryonic developmental potential and optimizing in vitro culture conditions. Collectively, these applications provide a strong foundation for improving ART success rates and advancing personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.